Cholesteryl ester transfer protein inhibition with anacetrapib decreases fractional clearance rates of high-density lipoprotein apolipoprotein A-I and plasma cholesteryl ester transfer protein

Gissette Reyes-Soffer, John S. Millar, Colleen Ngai, Patricia Jumes, Ellie Coromilas, Bela Asztalos, Amy O. Johnson-Levonas, John A. Wagner, Daniel S. Donovan, Wahida Karmally, Rajasekhar Ramakrishnan, Stephen Holleran, Tiffany Thomas, Richard L. Dunbar, Emil M. Degoma, Hashmi Rafeek, Amanda L. Baer, Yang Liu, Michael E. Lassman, David E. GutsteinDaniel J. Rader, Henry N. GinsbergShow 2 othersShow less